Search results

Page results

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• UCL, UCLH and Formula One develop life-saving breathing aids for the NHS

  A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.

• Cancer immunotherapy treatment

  This page is for cancer patients receiving immunotherapy treatment.

• Gastroscopy – a guide for patients

  This page explains what a gastroscopy is and what it involves.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• Launch of new services to support patients with sickle cell disease, thalassaemia, and other inherited red cell disorders

  The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.

• Launch of new services to support patients with sickle cell disease, thalassaemia, and other inherited red cell disorders

  The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.